Now, following up on that success, a large Chinese collaboration has followed up with a description of an improved gene ...
The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling ...
CRISPR’s promise of curing diseases hit a setback when researchers discovered that AZD7648, a molecule designed to improve precision, also caused catastrophic hidden damage to DNA. Instead of perfect ...
With the first medical therapy approved and systems like CRISPR-Cas showing up in complex cells, there’s a lot happening in the genome editing field. By Amber Dance/Knowable Magazine Published Jan 26, ...
In December 2020, the New England Journal of Medicine published a paper titled CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia, marking an exciting new chapter in the treatment of ...
Gene editing in plants remains challenging, with the traditional non-homologous end-joining (cNHEJ) repair pathway often hindering precision. In this study, researchers advanced CRISPR-Cas-based gene ...
The cryogenic electron microscope structure of the A4p-activated (green) CalpL protein filament (violet) from Candidatus Cloacimonas acidaminovorans (PDB ID: 9EYJ). CRISPR-Cas systems help to protect ...
Individuals with genetic diseases have an increased chance of lower quality of life. However, a new technology has been developed that could edit DNA and take out possible mutations resolving genetic ...
MaxCyte’s Flow Electroporation technology delivers CRISPR/Cas-9 gene-editing tools to a patient’s T cells. The technology uses electrical pulses to create temporary pores in the cell membrane, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results